Skip to content

Tag «Drug»

White House Plan to Cut Drug Prices Gets Shrugs From Investors

White House Plan to Cut Drug Prices Gets Shrugs From Investors

Biotech and Pharma Barron’s Take By Josh Nathan-Kazis Dec 07, 2023, 12:45 pm EST Share Reprints The Biden administration’s assertion Thursday that it can break the patents of certain high-price drugs could represent a significant challenge to the drug industry, but its practical implications appear limited, at least for now. Continue reading this article with …